Epidemiology and Risk Factors of Uterine Fibroids in China
ConditionUterine Fibroid
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorWenwen Wang
About this trial
Uterine fibroids are the most common form of benign uterine tumors in the uterine muscle layer, which had a certain rate of malignancy, but it is rare. The prevalence of uterine fibroids estimates range from 4.5% to 68.6% depending on study population and diagnostic methodology. The prevalence of fibroids has been historically underestimated by epidemiologic studies which focused mainly on symptomatic women, leaving behind a large population of asymptomatic women and women who underreport their symptoms. What investigators don't know was which women who have fibroids will develop clinical symptoms and which women who have an operation of myomectomy will relapse. The purpose of this study is to investigate the prevalence, incidence and risk factors for the development of uterine fibroids in Chinese women.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Current place of residence≥ 6 months;
No serious mental illness or mental abnormality;
Those who agree to participate in this survey and cooperate in completing the questionnaire.
Disqualifiers
None
Trial population
This study population is women aged more than 18yrs with or without uterine fibroids from five regions of China. The study time period will conduct from May 1, 2023 - November 30, 2025 to allow for 6 months pre-index for evaluating baseline demographic and clinical characteristics and 24 months post-index, ensuring a minimum of one years follow-up.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Prevalence of uterine fibroids in China
Prevalence of uterine fibroids in China
Time frame
BaselineSecondary outcomes
1
Incidence of uterine fibroids in China
Incidence of uterine fibroids in China
Time frame
Two follow-ups over a three-year period2
Risk factors of development of uterine fibroids in China
Associated risk factors for recurrence, infertility and malignancy of uterine fibroids in China
Time frame
Two follow-ups over a three-year periodSponsors and contacts
Click on the lead sponsor to view all of their trials.
Wenwen Wang
Lead sponsor
Tongji Hospital
Sponsor institution
Women's Hospital School Of Medicine Zhejiang University
Collaborator
Tongji Hospital
Collaborator
First Affiliated Hospital, Sun Yat-Sen University
Collaborator
West China Hospital
Collaborator
The Fourth Hospital of Shijiazhuang
Collaborator
Source ClinicalTrials.gov